On March 22, 2026, Totaligent, Inc. announced that it has entered into an Extension Amendment to its Binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company. This amendment extends the target date for the negotiation and execution of definitive agreements related to a proposed joint venture and acquisition of GloMed's business operations, intellectual property, and related assets. The new target closing date is set for April 22, 2026, allowing additional time for negotiations and due diligence. The exclusivity period outlined in the LOI has also been extended through this date. The company previously disclosed the LOI in its Current Report on Form 8-K filed on February 23, 2026. The extension is seen as a positive step, providing Totaligent with more time to finalize the terms of the agreement, which could enhance its operational capabilities and market position if successfully executed.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.